Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with graves' ophthalmopathy undergoing orbital radiotherapy

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2244-2247

  Hofbauer, Lorenz C ^a,d   Mühlberg, Tina ^b   König, August ^a   Heufelder, Gabriela ^c   Schworm, Hermann Dieter ^a   Heufelder, Armin E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum St Georg   (Germany)

^c Augenpraxis Prof Neuhann   (Germany)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; MALE; ORBIT; PRIORITY JOURNAL; RADIOTHERAPY; SMOKING;

ADULT; AGE FACTORS; FEMALE; GRAVES DISEASE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; SEX FACTORS; SMOKING; TIME FACTORS;

EID: 0030811018     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.7.2244     Document Type: Article

References (30)

1. Weetman AP. 1991 Thyroid-associated eye disease: pathophysiology. Lancet. 2:25-28.
2. Bahn RS, Heufelder AE. 1993 Mechanisms of disease: Graves' ophthalmopathy. N Engl J Med. 329:1468-1475.
3. Burch HB, Wartofsky I. 1993 Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 14:747-493.
4. Heufelder AE. 1995 Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Eur J Endocrinol. 132:532-541.
5. Heufelder AE, Bahn RS. 1993 Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest. 23:10-17.
6. Dinarello CA. 1996 Biologic basis for interleukin-1 in disease. Blood. 87:2095-2147.
7. Dinarello CA. 1991 Interleukin-1 and interleukin-1 antagonism. Blood. 77:1627-1652.
8. Dinarello CA, Wolff SM. 1993 Mechanisms of disease: The role of interleukin-1 in disease. N Engl J Med. 328:106-113.
9. Firestein GS, Boyle DL, Yu C, et al. 1994 Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum. 37:644-652.
10. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. 1995 Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 154:2434-2440.
11. Chomarat P, Vannier E, Dechanet J, et al. 1995 Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol. 154:1432-1439.
12. Müller B, Zulewski H, Huber P, Ratcliffe JG, Staub J-J. 1995 Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med. 333:964-969.
13. Sepkovic DW, Haley NJ, Wynder EL. 1984 Thyroid activity in cigarette smokers. Arch Intern Med. 144:501-503.
14. Christensen SB, Ericsson UB, Janzon L, Tibblin S, Melander A. 1984 Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab. 58:615-618.
15. Ericsson UB, Lindgärde F. 1991 Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis, and autoimmune thyroiditis. J Intern Med. 229:67-71.
16. Hegedüs L, Karstrup S, Veiergang D, Jacobsen B, Stovsted L, Feldt-Rasmussen U. 1985 High frequency of goitre in cigarette smokers. Clin Endocrinol (Oxf). 22:287-292.
17. Bertelsen JB, Hegedüs L. 1994 Cigarette smoking and the thyroid. Thyroid. 4:327-331.
18. Metcalfe RA, Weetman AP. 1994 Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: Possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf). 40:67-72.
19. Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell'Unto E, Martino E. 1995 Cigarette smoking and the thyroid. Eur J Endocrinol. 133:507-512.
20. Shine B, Fells P, Edwards OM, Weetman AP. 1990 Association between Graves' ophthalmopathy and smoking. Lancet. 2:1261-1263.
21. Tellez M, Cooper J, Edmonds C. 1992 Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol (Oxf). 36:291-294.
22. Prummel MF, Wiersinga WM. 1993 Smoking and risk of Graves' disease. JAMA. 269:479-482.
23. Francus T, Manzo G, Canki M, Thompson LC, Szabo P. 1989 Two peaks of interleukin-1 expression in human leukocyte cultures with tobacco glycoprotein. J Exp Med. 170:327-332.
24. Anonymous. 1993 Classification of the eye changes of Graves' disease. Thyroid. 2:235-236.
25. Zar JH. 1984 Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, pp 104-113.
26. Janson RW, King JTE, Hance KR, Arend WP. 1993 Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Resp Dis. 148:495-503.
27. Mühlberg T, Heberling H-J, Joba W, Schworm H-D, Scriba PC, Heufelder AE. 1996 Detection, localization, and regulation of soluble and intracellular interleukin-1 receptor antagonist gene and protein variants in Graves' ophthalmopathy. Proc of the 10th International Congress of Endocrinology, San Francisco, CA: P1-1044 (Abstract).
28. Donnelly SC, Strieter RM, Reid PT, et al. 1996 The associations between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 125:191-196.
29. Tan GH, Dutton CH, Bahn RS. 1996 Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 81:449-452.
30. Bartalena L, Marcocci C, Pinchera A. 1996 Cytokine antagonists: new ideas for the management of Graves' disease. J Clin Endocrinol Metab. 81:446-448.